cas 2497590-06-2|| where to buy (5S,8S,10aR)-3-acetyl-5-(tert-butoxycarbonylamino)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid

Nom du produit:(5S,8S,10aR)-3-acetyl-5-(tert-butoxycarbonylamino)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid

IUPAC Name:(5S,8S,10aR)-3-acetyl-5-{[(tert-butoxy)carbonyl]amino}-6-oxo-decahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid

: CAS：2497590-06-2; Formule moléculaire：C17H27N3O6; Pureté：95%+

: Numéro de catalogue：CM1018630; Poids moléculaire：369.42

Unité d'emballage	Stock disponible	Prix($)
CM1018630-250mg	in stock	ȅȖȯ
CM1018630-500mg	in stock	ŪȯƐ
CM1018630-1g	in stock	ȯŞƚ
CM1018630-5g	1-2 Weeks	ƴǫƐƚ
CM1018630-10g	1-2 Weeks	ȖȅŪƚ

Demande: sales@chemenu.com

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2497590-06-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

Détails du produit

: N° CAS:2497590-06-2; Formule moléculaire:C17H27N3O6; Point de fusion:-; Code SMILES:CC(=O)N1CC[C@H]2CC[C@@H](C(=O)O)N2C(=O)[C@@H](NC(=O)OC(C)(C)C)C1; Densité:

: Numéro de catalogue:CM1018630; Poids moléculaire:369.42; Point d'ébullition:; N° Mdl:; Stockage:

Category Infos

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

Column Infos

: KT-333; Kymera shared new clinical data from its ongoing KT-333 Phase 1 trial. KT-333, a first-in-class, potent, highly selective, heterobifunctional small molecule degrader of STAT3, demonstrated antitumor responses in hematological malignancies with high unmet need, including relapsed/refractory classic Hodgkin’s lymphoma (cHL), cutaneous T-cell lymphoma (CTCL), and NK-cell lymphoma, at doses that were well-tolerated.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Formulaire de demande

Détails du produit

Category Infos

Column Infos

Related Products